Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Fourth View: Looking at the standard of care and development of AXS-05 in treating patients with major depressive disorder (MDD)

Ticker(s): AXSM

Who's the expert?

Institution: RUHS

Board certified in General Psychiatry and Addiction Medicine
Manages 300 patients with MDD and about 50 cases of people with opioid use disorder.

Interview Goal

Discuss the current standard of care and new therapies in development including AXS-05 ( dextromethorphan-bupropion ) an oral, investigational NMDA receptor antagonist

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.